Genetic instability and darwinian selection in tumours - PubMed (original) (raw)

Affiliations

• PMID: 10611684

Free article

Review

Genetic instability and darwinian selection in tumours

D P Cahill et al. Trends Cell Biol. 1999 Dec.

Free article

Abstract

Genetic instability has long been hypothesized to be a cardinal feature of cancer. Recent work has strengthened the proposal that mutational alterations conferring instability occur early during tumour formation. The ensuing genetic instability drives tumour progression by generating mutations in oncogenes and tumour-suppressor genes. These mutant genes provide cancer cells with a selective growth advantage, thereby leading to the clonal outgrowth of a tumour. Here, we discuss the role of genetic instability in tumour formation and outline future work necessary to substantiate the genetic instability hypothesis.

PubMed Disclaimer

Similar articles

• TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
  Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. Olivier M, et al. IARC Sci Publ. 2004;(157):247-70. IARC Sci Publ. 2004. PMID: 15055300 Review.
• Can chromosomal instability initiate tumorigenesis?
  Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA. Michor F, et al. Semin Cancer Biol. 2005 Feb;15(1):43-9. doi: 10.1016/j.semcancer.2004.09.007. Semin Cancer Biol. 2005. PMID: 15613287 Review.
• Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability.
  Guenot D, Guérin E, Aguillon-Romain S, Pencreach E, Schneider A, Neuville A, Chenard MP, Duluc I, Du Manoir S, Brigand C, Oudet P, Kedinger M, Gaub MP. Guenot D, et al. J Pathol. 2006 Apr;208(5):643-52. doi: 10.1002/path.1936. J Pathol. 2006. PMID: 16450341
• Immune selection in neoplasia: towards a microevolutionary model of cancer development.
  Pettit SJ, Seymour K, O'Flaherty E, Kirby JA. Pettit SJ, et al. Br J Cancer. 2000 Jun;82(12):1900-6. doi: 10.1054/bjoc.2000.1206. Br J Cancer. 2000. PMID: 10864195 Free PMC article. Review.
• Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
  Bignold LP. Bignold LP. Carcinogenesis. 2004 Mar;25(3):299-307. doi: 10.1093/carcin/bgh013. Epub 2003 Nov 6. Carcinogenesis. 2004. PMID: 14604890

Cited by

• Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler.
  Böning S, Schneider F, Huber AK, Langhoff D, Lin H, Kaczorowski A, Stenzinger A, Hohenfellner M, Duensing S, Duensing A. Böning S, et al. Immunooncol Technol. 2024 Aug 20;23:100727. doi: 10.1016/j.iotech.2024.100727. eCollection 2024 Sep. Immunooncol Technol. 2024. PMID: 39310847 Free PMC article. Review.
• Genetic variation drives cancer cell adaptation to ECM stiffness.
  Wang TC, Sawhney S, Morgan D, Bennett RL, Rashmi R, Estecio MR, Brock A, Singh I, Baer CF, Licht JD, Lele TP. Wang TC, et al. Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2403062121. doi: 10.1073/pnas.2403062121. Epub 2024 Sep 20. Proc Natl Acad Sci U S A. 2024. PMID: 39302966 Free PMC article.
• Integrating frontiers: a holistic, quantum and evolutionary approach to conquering cancer through systems biology and multidisciplinary synergy.
  Casotti MC, Meira DD, Zetum ASS, Campanharo CV, da Silva DRC, Giacinti GM, da Silva IM, Moura JAD, Barbosa KRM, Altoé LSC, Mauricio LSR, Góes LSBB, Alves LNR, Linhares SSG, Ventorim VDP, Guaitolini YM, Dos Santos EVW, Errera FIV, Groisman S, de Carvalho EF, de Paula F, de Sousa MVP, Fechine PBA, Louro ID. Casotti MC, et al. Front Oncol. 2024 Aug 19;14:1419599. doi: 10.3389/fonc.2024.1419599. eCollection 2024. Front Oncol. 2024. PMID: 39224803 Free PMC article. Review.
• Cancer, metastasis, and the epigenome.
  Kiri S, Ryba T. Kiri S, et al. Mol Cancer. 2024 Aug 2;23(1):154. doi: 10.1186/s12943-024-02069-w. Mol Cancer. 2024. PMID: 39095874 Free PMC article. Review.
• 2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway.
  Schaufelberger SA, Schaettin M, Azzarito G, Rosselli M, Leeners B, Dubey RK. Schaufelberger SA, et al. Cells. 2024 Jun 22;13(13):1086. doi: 10.3390/cells13131086. Cells. 2024. PMID: 38994940 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database